Effect of Medicare coverage on use of invasive colorectal cancer screening tests

Archives of Internal Medicine

Volumn 162, Issue 22, 2002, Pages 2581-2586

  Ko, Cynthia W ^a   Kreuter, William ^a   Baldwin, Laura Mae ^b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AMBULATORY CARE; ARTICLE; BARIUM ENEMA; COLONOSCOPY; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; HEALTH CARE UTILIZATION; HUMAN; INCIDENCE; INSURANCE; MAJOR CLINICAL STUDY; MALE; MEDICARE; OCCULT BLOOD TEST; PRIORITY JOURNAL; RACE; REIMBURSEMENT; RETROSPECTIVE STUDY; SCREENING TEST; SEX DIFFERENCE; SIGMOIDOSCOPY; UNITED STATES;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; COLONOSCOPY; COLORECTAL NEOPLASMS; FEMALE; HEALTH SERVICES MISUSE; HUMANS; INSURANCE COVERAGE; LOGISTIC MODELS; MALE; MASS SCREENING; MEDICARE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PATIENT ACCEPTANCE OF HEALTH CARE; PROBABILITY; RETROSPECTIVE STUDIES; WASHINGTON;

EID: 0037049365     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.22.2581     Document Type: Article

References (29)

1. Surveillance, Epidemiology, and End Results (SEER) Program, 1973-1996. In: Ries LAG, Kosary CL, Hankey BF, Clegg L, Edwards BK, eds. SEER Cancer Statistics Review, 1973-1996. Bethesda, Md: National Cancer Institute; 1999.
2. Winawer SJ, St John DJ, Bond JH, et al. Prevention of colorectal cancer: Guidelines based on new data. Bull World Health Organ. 1995;73:7-10.
3. Winawer SJ, Fletcher RH, Miller L, et al. Colorectal cancer screening: Clinical guidelines and rationale. Gastroenterology. 1997;112:594-642.
4. US Preventive Services Task Force. Screening for colorectal cancer: Recommendation and rationale. Ann Intern Med. 2002;137:129-131.
5. Byers T, Levin B, Rothenberg D, Dodd GD, Smith RA. American Cancer Society guidelines for screening and surveillance for early detection of colorectal polyps and cancer: Update 1997. CA Cancer J Clin. 1997;47:154-160.
6. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472-1477.
7. Kronberg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348:1467-1471.
8. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med. 1993;328:1365-1371.
9. Selby JV, Friedman GD, Quesenberry CP, Weiss MS. Effect of fecal occult blood testing on mortality from colorectal cancer: A case-control study. Ann Intern Med. 1993;118:1-6.
10. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med. 1992;326:653-657.
11. Newcomb PA, Norfleet RG, Storer BE, Surawicz T, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst. 1992;84:1572-1575.
12. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med. 1995;155:1741-1748.
13. Rex DK, Johnson DA, Lieberman DA, Burt RW, Sonnenberg A. Colorectal cancer prevention 2000: Screening recommendations from the American College of Gastroenterology. Am J Gastroenterol. 2000;95:868-877.
14. Centers for Disease Control and Prevention. Screening for colorectal cancer - United States, 1997. MMWR Morb Mortal Wkly Rep. 1999;48:116-121.
15. Centers for Disease Control. and Prevention. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep. 2001;50:162-166.
16. Dartmouth Medical School, Center for Evaluative Clinical Sciences. The. Quality of Medical Care in the United States: A Report on the Medicare Program. 3rd Ed. Chicago, Ill: American Hospital Publishing; 1999.
17. Winawer SJ, Stewart ET, Zauber AG, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med. 2000;243:1766-1772.
18. Fletcher RH. The end of barium enemas? N Engl J Med. 2000;243:1823-1824.
19. McBean AM, Gornick M. Differences in the rates of procedures performed in hospitals for Medicare beneficiaries. Health Care Financ Rev. 1994;15:77-90.
20. Peterson ED, Wright SM, Daley J, Thibault GE. Racial variation in cardiac procedure use and survival following acute myocardial infarction in the Department of Veterans Affairs. JAMA. 1994;271:1175-1180.
21. Steingart RM, Packer M, Hamm P, et al. Sex differences in the management of coronary heart disease. N Engl J Med. 1991;325:226-230.
22. Fisher ES, Whaley FS, Krushat WM, et al. The accuracy of Medicare's hospital claims data: Progress has been made but problems remain. Am J Public Health. 1992;82:243-248.
23. Javitt JC, McBean AM, Sastery SS, DiPaolo F. Accuracy of coding in Medicare Part B claims: Cataract as a case study. Arch Ophthalmol. 1993;111:605-607.
24. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of screening tests: Results from the 1992 National Health Interview Survey. Med Care. 1998;26:257-270.
25. Nelson RL, Dollear T, Freels S, Persky V. The relation of age, race, and gender to the subsite location of colorectal carcinoma. Cancer. 1997;80:193-197.
26. Theuer CP, Wagner JL, Taylor TH, et al. Racial and ethnic colorectal cancer patterns affect the cost-effectiveness of colorectal cancer screening in the United States. Gastroenterology. 2001;120:848-856.
27. Pignone M, Harris R, Kinsinger L. Videotape-based decision aid for colon cancer screening: A randomized, controlled trial. Ann Intern Med. 2000;133:761-769.
28. Garr DR, Ornstein SM, Jenkins RG, Zemp LD. The effect of routine use of computer-generated preventive reminders in a clinical practice. Am J Prev Med. 1993;9:55-61.
29. Thompson NJ, Boyko EJ, Dominitz JA, et al. A randomized controlled trial of a clinic-based support staff intervention to increase the rate of fecal occult blood test ordering. Prev Med. 2000;30:244-251.